- Home
- ACTG vs SLP Comparison
ACTG vs SLP Comparison
Compare ACTG & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACTG | SLP |
|---|---|---|
| Founded | 1993 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Multi-Sector Companies | EDP Services |
| Sector | Miscellaneous | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 384.9M | 367.9M |
| IPO Year | 1995 | 1996 |
Fundamental Metrics
Financial Performance| Metric | ACTG | SLP |
|---|---|---|
| Price | $4.54 | $18.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 6 |
| Target Price | $6.00 | ★ $24.00 |
| AVG Volume (30 Days) | 256.4K | ★ 592.1K |
| Earning Date | 05-07-2026 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 161.11 | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | $12,004,000.00 | ★ $59,577,000.00 |
| Revenue This Year | N/A | $3.80 |
| Revenue Next Year | N/A | $5.90 |
| P/E Ratio | ★ N/A | $70.73 |
| Revenue Growth | N/A | ★ 10.52 |
| 52 Week Low | $3.12 | $11.09 |
| 52 Week High | $5.27 | $21.01 |
Technical Indicators
Market Signals| Indicator | ACTG | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 39.18 | 67.98 |
| Support Level | $4.53 | $17.74 |
| Resistance Level | $5.20 | $18.57 |
| Average True Range (ATR) | 0.12 | 0.25 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 0.00 | 88.58 |
Price Performance
Historical ComparisonAbout ACTG Acacia Research Corporation (Acacia Tech)
Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, capital base, and deep industry relationships to drive value. The company has four reportable business segments: Intellectual Property Operations, Industrial Operations, Energy Operations and Manufacturing Operations. It derives revenue from Intellectual Property Operations segment. Geographically, it operates in Americas, Europe, Middle East and Africa, China, India, and Asia-Pacific, excluding China and India.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.